We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
+14.45%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$43.5B
AUM Growth
+$6.37B
Cap. Flow
+$123M
Cap. Flow %
0.28%
Top 10 Hldgs %
9.32%
Holding
3,484
New
550
Increased
1,237
Reduced
1,116
Closed
366

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$301M
2
TSLA icon
Tesla
TSLA
+$254M
3
NKE icon
Nike
NKE
+$248M
4
PG icon
Procter & Gamble
PG
+$233M
5
PFE icon
Pfizer
PFE
+$232M

Sector Composition

Rank Sector Weight
1 Technology 18.09%
2 Financials 10.23%
3 Consumer Discretionary 10.17%
4 Healthcare 10.17%
5 Industrials 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIME
3026
Algorhythm Holdings
RIME
$5.67M
$12.5K ﹤0.01%
62
-102
-62% -$20.1K
ITP icon
3027
IT Tech Packaging
ITP
$2.99M
$12.4K ﹤0.01%
40,170
PSNYW icon
3028
Polestar Automotive Holding ADS Class C-1
PSNYW
$397M
$12.4K ﹤0.01%
1,722
ALGS icon
3029
Aligos Therapeutics
ALGS
$40.4M
$12.4K ﹤0.01%
745
-172
-19% -$2.96K
BIOL
3030
DELISTED
Biolase, Inc.
BIOL
$12K ﹤0.01%
+10,726
New +$15.3K
SMR.WS
3031
DELISTED
NuScale Power Corporation Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SMR.WS
$11.5K ﹤0.01%
37,200
+11,300
+44% +$4.72K
INBS icon
3032
Intelligent Bio Solutions
INBS
$7.24M
$11.5K ﹤0.01%
+284
New +$11.2K
TAOX
3033
Tao Synergies Inc
TAOX
$29.2M
$11.5K ﹤0.01%
+1,688
New +$12.2K
HPCO
3034
DELISTED
Hempacco Co., Inc. Common Stock
HPCO
$11.1K ﹤0.01%
3,276
-1,065
-25% -$3.81K
CMRX
3035
DELISTED
Chimerix, Inc.
CMRX
$10.9K ﹤0.01%
+11,300
New +$10.9K
VCNX
3036
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$10.7K ﹤0.01%
+1,154
New +$13.6K
GLMD icon
3037
Galmed Pharmaceuticals
GLMD
$4.22M
$10.7K ﹤0.01%
245
-75
-23% -$2.86K
MLGO
3038
MicroAlgo
MLGO
$45.5M
$10.5K ﹤0.01%
+2
New +$35.6K
SLGCW
3039
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$10.3K ﹤0.01%
+86,137
New +$12.3K
MRIN
3040
DELISTED
Marin Software
MRIN
$9.85K ﹤0.01%
4,478
+562
+14% +$1.22K
SES.WS
3041
DELISTED
SES AI Corp Warrants
SES.WS
$9.72K ﹤0.01%
+56,326
New +$10.1K
SNGX icon
3042
Soligenix
SNGX
$8.91M
$8.88K ﹤0.01%
+733
New +$6.41K
AQMS icon
3043
Aqua Metals
AQMS
$10.3M
$8.82K ﹤0.01%
58
-50
-46% -$8.9K
WIMI
3044
WiMi Hologram Cloud
WIMI
$25.9M
$8.57K ﹤0.01%
1,059
-2,900
-73% -$19.7K
CTHR
3045
DELISTED
Charles & Colvard Ltd
CTHR
$7.73K ﹤0.01%
1,884
-290
-13% -$1.2K
SRXH
3046
SRX Global
SRXH
$25.8M
$7.68K ﹤0.01%
+14
New +$6.84K
PVLA
3047
Palvella Therapeutics
PVLA
$2B
$7.45K ﹤0.01%
511
-19
-4% -$348
SST.WS
3048
DELISTED
System1, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SST.WS
$7.31K ﹤0.01%
45,700
PAYOW
3049
DELISTED
Payoneer Global Inc. Warrant
PAYOW
$7.12K ﹤0.01%
20,731
FTH
3050
Faeth Therapeutics
FTH
$824M
$7.04K ﹤0.01%
509
-35
-6% -$478

Similar funds

John Overdeck's Q4 2023 Portfolio in Review

As of Q4 2023, John Overdeck held 3,484 positions worth $43.5B, up 17% from $37.2B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

John Overdeck's Q4 2023 filing shows 550 new, 1,237 increased, 1,116 reduced and 366 closed positions. Its largest new stake was Becton Dickinson: 732,254 shares worth $179M. The largest sale was Palantir, an estimated $301M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • John Overdeck's largest Q4 2023 buy was Becton Dickinson: 732,254 shares worth $179M.
  • John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $976M increase.
  • John Overdeck's biggest Q4 2023 reduction was Palantir, cutting an estimated $301M.
  • John Overdeck fully exited Tesla in Q4 2023, selling an estimated $254M.
  • John Overdeck's ten largest holdings make up 9.3% of its $43.5B portfolio in Q4 2023.
  • John Overdeck opened 550 new positions and closed 366 in Q4 2023.
  • John Overdeck's portfolio value rose 17% quarter-over-quarter to $43.5B.

Based on Two Sigma Investments's 13F filing for Q4 2023, filed 14 Feb 2024.